Next |
home / stock / sabs / sabs message board
Subject | By | Source | When |
---|---|---|---|
$SABS bears are running | XenaLives | investorshub | 05/14/2023 11:30:21 PM |
$SABS should we be shorting? | crudeoil24 | investorshub | 05/13/2023 2:03:54 AM |
Price gaining | XenaLives | investorshub | 05/11/2023 12:26:26 AM |
The gaining | XenaLives | investorshub | 05/09/2023 12:34:18 PM |
$SABS The now | XenaLives | investorshub | 05/06/2023 2:17:08 PM |
$SABS bulls and bears | XenaLives | investorshub | 04/26/2023 10:46:45 PM |
$SABS Have a look at this | Awl416 | investorshub | 04/26/2023 7:06:11 AM |
Looks pretty positive | XenaLives | investorshub | 04/20/2023 5:13:56 PM |
Have a look at this | Jess070283 | investorshub | 04/19/2023 10:59:58 PM |
My swinger is aliveeee | Jess070283 | investorshub | 04/18/2023 2:11:23 PM |
1.11 High PM | Golden Cross | investorshub | 04/13/2023 12:13:34 PM |
Moving PM | Awl416 | investorshub | 04/13/2023 12:01:48 PM |
Historic short interest: | XenaLives | investorshub | 05/21/2022 1:32:00 AM |
Another great trade.$$$ Up up we go! | Jess070283 | investorshub | 03/31/2022 6:43:03 PM |
SABs government contract work is expected to provide | crudeoil24 | investorshub | 03/31/2022 6:24:02 PM |
Historic short interest: | XenaLives | investorshub | 03/17/2022 11:19:10 PM |
Historic short interest: | XenaLives | investorshub | 01/27/2022 1:54:22 PM |
Historic short interest: | XenaLives | investorshub | 12/30/2021 1:35:57 PM |
Chasing Stars: SABS Stock Chart Video Analysis 11-27-2021 SAB Biotherapeutics Inc. $SABS Today we ta | Chasing Stars | investorshangout | 11/27/2021 8:56:43 PM |
Historic short interest: | XenaLives | investorshub | 11/24/2021 10:02:36 PM |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc. Company Name:
SABS Stock Symbol:
NASDAQ Market:
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...
MIAMI BEACH, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), ("SAB" or the "Company"), a clinical-stage biop...
MIAMI BEACH, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...